- Correction
- Open access
- Published:
Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Molecular Cancer volume 19, Article number: 31 (2020)
Correction to: Molecular Cancer (2020) 19: 19
https://doi.org/10.1186/s12943-020-1144-6
After publication of the article [1], authors found out that Fig. 1 was inadvertently replaced. Correct Fig. 1 version is provided on this paper.
Reference
Ren D, Hua Y, Yu B, Ye X, He Z, Li C, Wang J, Mo Y, Wei X, Chen Y, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Zeng Z, Xiong W. Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Mol Cancer. 2020. https://doi.org/10.1186/s12943-020-1144-6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Ren, D., Hua, Y., Yu, B. et al. Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Mol Cancer 19, 31 (2020). https://doi.org/10.1186/s12943-020-01148-y
Published:
DOI: https://doi.org/10.1186/s12943-020-01148-y